SZSE Releases
News
Market Brief
Companies
Releases
Pricing
Home
/
Companies
/
Staidson (Beijing) BioPharmaceuticals Co., Ltd.
/
Release
300204
SZSE
Announcement on the Summary Report of Phase Ib Clinical Study for STSP-0902 Injection (for Treatment of Oligozoospermia)
Staidson (Beijing) BioPharmaceuticals Co., Ltd.
·
September 24, 2026
·
3 pages
Full Translation